ANZMTG 01.15 CHARLI A phase Ib/II trial of ipilimumab-nivolumab-denosumab and nivolumab-denosumab in patients with unresectable stage III and IV melanoma – Site Contact Details Site Name Address Country Principal Investigator Phone Email Address 305 Grattan Street, Peter MacCallum Cancer Centre Australia Dr Shahneen Sandhu 03 8559 5000 Shahneen.Sandhu@petermac.org Melbourne VIC 3000
ANZMTG 01.15 CHARLI – A phase Ib/II trial of ipilimumab-nivolumab-denosumab and nivolumab-denosumab in patients with unresectable stage III and IV melanoma Site Contact Details Site Name Address Country Principal Investigator Phone Email Address Peter MacCallum Cancer Centre 305 Grattan Street, Melbourne VIC 3000 Australia Dr Shahneen Sandhu 03 8559 5000 Shahneen.Sandhu@petermac.org